Source: International Congress 2017 – Clinical problems in lung diseases
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
N. Patel (Birmingham, United Kingdom). Management of Pulmonary Carcinoid. 743

Member's Comments

No comment yet.

Related content which might interest you: Primary Pulmonary Amyloidosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018 Is it Time for Endobronchial Therapy to Replace Surgery in the Treatment of Typical Endobronchial Carcinoid? Source: Virtual Congress 2020 – Interventional pulmonology: diagnostic and therapeutic approaches Year: 2020 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Postoperative Pulmonary Complications in Bronchial Asthma/Chronic Obstructive Pulmonary Disease/Non-Pulmonary Disease Patients Source: International Congress 2018 – Functional assessment of COPD Year: 2018 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Long-term Outcome of Pulmonary Resection for Nontuberculous Mycobacterial Pulmonary Disease Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies Year: 2017 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Clinical characteristics of a Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH)  Cohort Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 Pulmonary carcinoid tumours Source: ISSN=ISSN 1810-6838, ISBN=, page=322 Year: 2006 Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today Year: 2019 Poor Subpleural Perfusion as a predictor of Failure after Balloon Pulmonary Angioplasty for non-operable Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension Year: 2017 Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Management of spontaneous pneumothorax in patients with or without Birt-Hogg-Dubé syndrome Source: International Congress 2014 – ILDs 1 Year: 2014 Late Breaking Abstract - Balloon Pulmonary Angioplasty for the Treatment of Non Operable Chronic Thromboembolic Pulmonary Hypertension – Initial experience of a Belgian Center Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 The Value of Voluntary Cough Sounds for Diagnosis of Pulmonary Disease Source: International Congress 2018 – Clinical determinants of asthma and biomarkers Year: 2018 Outcomes in embolisations of pulmonary arterio-venous malformations Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Pulmonary Alveolar Microlithiasis: From Diagnosis to Transplant: An Indian Experience Source: International Congress 2019 – Lung transplantation: from bench to bedside Year: 2019